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Abstract 
Enediynes are organic molecules that readily undergo a thermal rearrangement, now commonly 
known as the Bergman cyclization, to a cyclic para diradical form. Interest in this rearrangement 
was renewed when it was found to be crucial to the mechanism of cytotoxicity in a variety of 
natural products containing the enediyne structural moiety. Cyclization of these molecules leads 
to DNA strand scission and ultimately cell death. Recent efforts by medicinal chemists to 
discover therapeutically relevant enediyne derivatives have been complemented by 
computational approaches, which seek to compute energies and energetic barriers to cyclization 
that can accurately predict the behavior of these molecules in vivo. Here we demonstrate this 
approach for cis-hex-3-ene-1,5-diyne and two of its analogs using density functional theory, 
discuss the validity of its predictions, and investigate the effect of basis set on the description of 
these molecules’ reactivity. 
 
 
1. Introduction 
1.1 The Bergman cyclization 
Research into enediyne molecules 
emerged from chemists’ persistent efforts to 
understand a chemical intermediate known 
as didehydrobenzene. For decades more 
commonly known in the literature as 
benzyne, the elusive molecular species, with 
molecular formula C6H4, is generated by the 
removal of two hydrogen atoms from 
benzene, C6H6 (Figure 1). Due to the 
symmetry of the parent benzene molecule, 
didehydrobenzene may have three isomers: 
the ortho isomer, in which the removed 
hydrogen atoms are bonded to adjacent 
carbon atoms on the ring (Figure 2a); the 
meta isomer, in which they are separated by 
one intervening carbon atom (Figure 2b); 
and the para isomer, in which they are 
separated by two intervening carbon atoms, 
located directly across the six-membered 
ring from one another (Figure 2c).  These 
isomers have held the interest of many 
	  
Figure	  1.	  One	  of	  organic	  
chemistry’s	  classic	  molecular	  
structures:	  benzene.	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organic and physical chemists for the greater 
part of the 20th century; understanding the 
molecules and even determining whether 
they exist was of great interest to scientists 
interested in the mechanisms of organic 
reactions, synthetic pathways, and even 
bonding theory. 
The very existence of any of the 
didehydrobenzene isomers was first 
postulated in 1927, when Bachmann and 
Clarke found the reaction of chlorobenzene 
and sodium to yield, in addition to expected 
products, some species that they reasoned 
could only be generated by a free radical 
mechanism. Both mono- and diradical 
species were proposed in their paper, with 
the diradical species taking the form of the 
ortho isomer.[1] The hypothesis was further 
advanced by Georg Wittig, who in 1942 
predicted the intermediate when he observed 
the rates of reaction of phenyllithium with 
various halobenzenes to produce biphenyl, 
which ran contrary to what would have been 
expected had the reaction proceeded under a 
different mechanism.[2] Due to an 
observation of the reactivity of two 
fluoroanisole isomers from a previous study 
he had performed,[3] he predicted the 
intermediate took the form of an asymmetric 
zwitterion (Figure 3a), explicitly rejecting 
symmetric  intermediates like the triple-
bonded aryne form (Figure 3b); only in 1955 
were these observations found to be relics of 
experimental error upon replication.[4] By 
this time, the structure of the intermediate 
had been more definitively resolved by John 
D. Roberts’s classic study, in which 
chlorobenzene synthesized with one 14C 
atom bonded to the chlorine atom was 
reacted with potassium amide. The observed 
1:1 product ratio of aniline-1-14C and 
aniline-2-14C clearly demonstrated the 
intermediate didehydrobenzene was 
electrically neutral and symmetrical.[5]  The 
gradual adoption of resonance theory and 
molecular orbital theory in organic 
chemistry during this time led contemporary 
chemists to consider the ortho 
didehydrobenzene as a hybrid of diradical, 
aryne, and even to some extent zwitterionic 
resonance contributors. 
 
The meta and para isomers remained 
largely a mystery at this time, though some 
tenacious scientists continued to pursue 
them. Physical organic chemist Robert 
Bergman surmised that the para isomer 
might be generated transiently by provoking 
a thermal rearrangement of a molecule 
called cis-hex-3-ene-1,5-diyne (“enediyne,”  
Figure	  2.	  The	  three	  isomers	  of	  didehydrobenzene	  (as	  diradical	  
structures):	  (a)	  ortho;	  (b)	  meta;	  (c)	  para	  
Figure	  3.	  Two	  	  proposed	  structural	  forms	  of	  the	  ortho	  
didehydrobenzene:	  (a)	  an	  asymmetric,	  zwitterionic	  form;	  (b)	  
an	  electrically	  neutral	  and	  symmetric	  aryne	  form.	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Figure 4a), whose synthesis and isolation 
had been published throughout the 1960s.[6,7] 
Due to the symmetry of the molecule and 
the likely rapidness of the conversion, 
Bergman modified the synthesis to 
incorporate deuterium (2H) at both its 
acetylenic positions so that upon 
rearrangement, it would equilibrate with the 
structural isomer with deuterium at both its 
vinyl positions (Figure 4b). Analysis of the 
mixture produced after heating the 
compound showed a 1:1 ratio of the two 
structural isomers he expected with no other 
patterns of deuterium distribution detected, 
convincing Bergman that the rearrangement 
indeed proceeded through a species with the 
same symmetry as the suspected para 
didehydrobenzene.[8] However, this 
information didn’t clarify the structure of the 
species – and the structural “contenders” for 
this didehydrobenzene isomer were even 
more numerous than there were for the ortho 
isomer – nor did it clarify whether it was 
accessed as an intermediate or merely a 
transition state. 
 
To resolve the first issue, the 
enediyne was heated in a number of 
different reagents that might intercept the 
intermediate species; for example, heating it 
in a particular hydrocarbon resulted in the 
rapid generation of benzene and loss of 
starting material. The results put forth strong 
evidence for the diradical structure of the 
para didehydrobenzene, as radical 
molecules were virtually the only ones 
known to remove hydrogen atoms from 
hydrocarbons. Estimates of heat of 
formation gleaned by group equivalent 
techniques suggested that the 
didehydrobenzene was approximately only 
14 kcal mol-1 higher in energy than the 
enediyne. Bergman noted that, if the species 
were a transition state, the rearrangement 
would proceed at room temperature if the 
	  
	  
Figure	  4.	  The	  Bergman	  cyclization.	  (a)	  
According	  to	  Bergman’s	  proposed	  
mechanism,	  the	  enediyne	  molecule	  would	  
rearrange	  upon	  heating	  to	  transiently	  
form	  a	  para	  didehydrobenzene.	  Note	  that	  
the	  enediyne	  structures	  on	  the	  left	  and	  
right	  are	  equivalent.	  (b)	  Incorporating	  
deuterium,	  indicated	  here	  as	  D,	  at	  the	  
acetylenic	  positions	  of	  the	  enediyne	  
allowed	  Bergman	  to	  test	  whether	  this	  
mechanism	  was	  reasonable;	  note	  that	  by	  
making	  this	  modification,	  the	  structures	  
on	  the	  left	  and	  right	  are	  now	  distinct.	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energetic barrier were only this high; 
because this did not occur, he concluded that 
the para didehydrobenzene was not a 
transition state, but an unstable intermediate. 
Impressively, he also guessed, in the 
absence of proper kinetic studies, that the 
transition state leading to the intermediate 
would be about 32 kcal mol-1 higher in 
energy than the enediyne, a prediction that 
turned out to be somewhat accurate.[9] 
Bergman’s studies on the rearrangement 
leading from the enediyne molecule to the 
transient para didehydrobenzene species and 
back again were published in 1972; that 
rearrangement is now widely known as the 
Bergman cyclization. 
1.2 Discovery of enediyne antibiotics and 
their mechanism of cytotoxicity 
  It took us until the 20th century to 
find enediynes and the para 
didehydrobenzene, but for all our brilliance, 
it turned out that some other organisms – 
bacteria, in fact – had already beaten us to 
the punch. The surprising biological 
relevance of enediynes was discovered in 
the midst of a program that sought to 
discover powerful natural products. In the 
early 1980s, a semi-automated colorimetric 
assay involving genetically engineered E. 
coli was developed to detect DNA damage 
in hopes of finding novel cytotoxic 
molecules. Of the 10724 fermentation broths 
tested, about 1% demonstrated significant 
DNA-damaging activity.[10] Some of the 
fermentation broths that tested positive came 
from the bacterium Micromonospora 
echinospora ssp calichensis, named after the 
caliche (chalky soil) sample in which it was 
found in Texas. From these broths, the 
calicheamicin family of molecules was 
isolated (Figure 5). The potency of these 
molecules was remarkable; in mouse 
models, they were approximately 1000 times 
as powerful as adriamycin, a cancer drug 
already in use at the time. 
Figure	  5.	  Calicheamicin	  γ’1,	  one	  of	  the	  natural	  enediyne	  antibiotics	  discovered	  in	  the	  1980s.	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The structures of the calicheamicins, 
determined by extensive spectroscopic 
investigation and published in their final 
revised form in 1989 (after a preliminary 
1987 publication), revealed an interesting 
surprise: the presence of the enediyne 
moiety embedded in a ten-membered 
ring.[11] Moreover, evidence emerging in the 
subsequent years suggested a truly awe-
inspiring mechanism of action (figure 6): 
first, the calicheamicin molecule binds to the 
minor groove of double helical DNA in a 
sequence-specific manner, with proper 
recognition mediated by its oligosaccharide 
tail;[12] next, attack of the central sulfur atom 
in the trisulfide group occurs by an external 
nucleophile, prompting an internal Michael 
addition at an unsaturated carbon atom, 
contracting the ring structure and thus 
triggering Bergman cyclization of the 
enediyne moiety.[13] Isotope labeling studies 
have revealed the mechanisms by which the 
generated diradical species cleaves DNA: 
the pathways are numerous and varied, 
occuring at 1’, 4’ and 5’ positions of the 
deoxyribose sugar.[14,15] In general, 
abstraction of a hydrogen atom from the 
deoxyribose sugar at these positions leads to 
the formation of unstable species, often 
causing double-stranded cleavage. 
Figure	  6.	  Mechanism	  by	  which	  calicheamicin	  γ’1	  effects	  DNA	  cleavage.	  An	  external	  nucleophile	  such	  as	  glutathione	  activates	  a	  “trigger”	  
group,	  causing	  structural	  changes	  that	  promote	  the	  Bergman	  cyclization	  of	  the	  enediyne	  moiety.	  The	  diradical	  that	  is	  generated	  in	  this	  
process	  then	  can	  cleave	  DNA.	  Adapted	  from	  E.	  Kraka,	  D.	  Cremer,	  J.	  Am.	  Chem.	  Soc.	  2000,	  122,	  8245.	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That biosynthetic pathways had 
produced enediyne-containing molecules, 
presumably as a defense for the organism, 
seemed remarkable. It wasn’t unique to 
Micromonospora’s molecules, either: 
enediynes kept emerging in other solved 
molecular structures around the same time, 
including esperamicin,[16] dynemicin,[17] and 
the neocarzinostatin chromophore,[18] whose 
structure was actually solved first but 
received little attention until its similarity to 
the calicheamicins was noted.[19] These 
molecules and others like them are now 
collectively known as the enediyne 
antibiotics. 
1.3 Design of enediyne analogs for use in 
cancer therapy 
 The discovery of nature’s ingenious 
and formidable use of the enediyne 
structural moiety has inspired chemists to 
design new enediyne derivatives with 
tailored properties. In general, slight 
modifications to the enediyne core produce 
molecules with very similar chemistry. For 
instance, take the 3-aza-enediyne (“aza-
enediyne,” Figure 7), which is produced by 
the replacement of one carbon atom in the 
enediyne by a nitrogen atom. This molecule 
may also undergo a Bergman-type 
cyclization to yield a diradical species; 
however, its retro-Bergman cyclization, the 
rearrangement in which the ring opens at the 
side opposite to that which initially 
“closed,” yields a distinct product from the 
starting material, unlike the enediyne 
(Figure 1a). While the rearrangements are 
expected to proceed by equivalent 
mechanisms to the rearrangements that the 
enediyne undergoes, the energetic barriers to 
the rearrangements are anticipated to be 
different, thus leading to a different 
distribution of products when the aza-
enediyne is heated. 
 Incorporating a ring structure behind 
the double-bonded portion of the structural 
moiety gives rise to even more interesting 
chemistry. Consider the 1,2-
dialkynylimidazole (Figure 8): retro-
Bergman cyclization leads to a curious-
looking nine-membered cumulene ring 
structure, and further rearrangement may 
lead to a carbene. Between each of these 
rearrangements exists a transition state, and 
thus an energetic barrier. The different 
energies of the various forms of the 
molecule and transition states dictates, 
again, which forms exist when the initial 
starting material is heated at a sufficient 
temperature. 
 The form of enediyne-based 
molecules known to exert its DNA-
damaging and cytotoxic activity is the 
diradical form. A therapeutic enediyne 
derivative, then, must be able to access this 
Figure	  7.	  Bergman	  
cyclization	  of	  aza-­‐
enediyne,	  proceeding	  
through	  a	  diradical	  
intermediate	  and	  
producing	  an	  
enynenitrile.	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form in order to damage the DNA of a 
disease-causing offender and eliminate it. 
But of course, these offenders reside within 
the human body, whose own DNA would be 
susceptible to such attack. How can this 
dilemma be resolved? 
 Assuming the DNA of both target 
and normal cells is accessible to an 
administered therapeutic enediyne 
derivative, the answer is simply that the two 
types of cells must differ sufficiently in 
environment such that the molecule assumes 
a harmful form in the target cell but a benign 
form in normal cells. This difference in 
conditions would represent a vulnerability to 
the molecule that the target cells have but 
that healthy human cells do not. Such 
vulnerabilities are often exploited in the 
molecular eradication of disease; for 
instance, an antibiotic may target a 
particular protein structure present in the 
bacterial form of an essential enzyme but 
not present in the human form, thus 
efficiently killing bacteria but leaving 
human cells unharmed. 
 Cancers are notoriously difficult 
diseases to treat because the differences in 
vulnerabilities between tumor and normal 
cells are often not very pronounced. Since 
tumor cells arise from many minor 
mutations to normal cells, they often have 
very similar vulnerabilities to the cells from 
which they came; a molecule effective in 
killing a tumor cell, then, often also does 
extensive collateral damage to normal cells. 
Nonetheless, research has revealed some 
consistent differences between normal and 
tumor cells that are being pursued in hopes 
of making cancer treatment more targeted 
and selective. Among these is the significant 
difference in pH of many tumor cells 
relative to their normal counterparts. Typical 
Figure	  8.	  Rearrangement	  of	  1,2-­‐dialkynylimidazole.	  This	  species	  may	  undergo	  a	  Bergman	  cyclization;	  the	  unusual	  cumulene	  ring	  structure	  
produced	  by	  the	  retro-­‐Bergman	  rearrangement	  may	  further	  rearrange,	  giving	  rise	  to	  a	  carbene	  species.	  
	   9	  
physiological pH is around 7.5; tumor cells, 
by contrast, are often found to be 
significantly more acidic, with pH 6.2 to 
6.6.[20] This difference likely arises because 
the vasculature of tumors cannot supply 
enough oxygen and other nutrients for the 
entire growing population of cells, leading 
many tumor cells to produce excess lactic 
acid under anaerobic conditions. Even more 
acidic conditions can be promoted in tumors 
by treatment with ionophores, bringing pH 
as low as 5.5.[21] 
 Thus, with this difference of 
conditions in mind, the goal of the rational 
design of an enediyne-based antitumor 
molecule becomes clear: design one 
molecule that will take the form of the 
DNA-damaging diradical under acidic 
conditions but that will take any other form 
under normal physiological conditions 
(Figure 9). This is a taller order than it may 
appear; satisfaction of the following criteria 
devised by Kraka and Cremer would 
produce a highly desirable molecule:[22] 
(1) the form of the molecule that it 
assumes under acidic conditions 
must have an energetic barrier to 
cyclization of less than 24 kcal mol-1 
in order to permit formation of the 
diradical at physiological 
temperature 
(2) all energetic barriers leading away 
from the diradical under acidic 
conditions should be much larger 
than the barrier to abstraction of 
hydrogen from DNA, or about 14 
kcal mol-1 
(3) the diradical under acidic conditions 
should have high hydrogen-
abstraction ability, as predicted by a 
small energetic singlet-triplet gap 
Figure	  9.	  An	  example	  of	  a	  hypothetical,	  ideal	  enediyne	  derivative	  with	  selective	  antitumor	  activity	  mediated	  by	  the	  pH	  difference	  between	  
normal	  and	  tumor	  cells.	  Under	  normal	  conditions,	  the	  molecule	  does	  not	  cyclize,	  thus	  sparing	  normal	  cells	  from	  DNA	  damage.	  The	  
protonation	  of	  the	  molecule	  in	  the	  tumor	  cell’s	  acidic	  environment	  promotes	  its	  cyclization	  to	  the	  diradical	  form,	  causing	  death	  of	  the	  
tumor	  cell.	  Note	  that	  under	  normal	  conditions,	  cyclization	  is	  permissible	  as	  long	  as	  the	  molecule	  rapidly	  converts	  to	  any	  form	  other	  than	  
the	  toxic	  diradical.	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(4) criteria 2 and 3 should not be 
satisfied by the molecule under 
neutral pH (normal physiological 
conditions); energies and energetic 
barriers must either prevent 
formation of a diradical altogether or 
only permit transient formation of a 
diradical before rapid conversion to a 
stabler, non-toxic form 
While this rationally based approach to 
designing enediyne therapies with as limited 
toxicity as possible has  emerged recently, 
other approaches have been undertaken as 
well. Success has been limited. 
Neocarzinostatin, one of the natural 
enediyne antibiotics mentioned above, has 
been approved in Japan for treatment of 
cancers of digestive organs.[23] Mylotarg, a 
monoclonal antibody linked to a 
calicheamicin-family molecule, was 
approved for treatment of certain acute 
myelogenous leukemia patients under the 
Food and Drug Administration’s accelerated 
approval program, which seeks to bring 
potential therapies for particularly life-
threatening diseases to the market more 
quickly, then follow up with more clinical 
trials  to validate the approval. Mylotarg did 
not hold up to this subsequent scrutiny; 
follow-up trials had to be halted early when 
no benefit was detected and higher death 
rate was observed in the experimental group, 
and Mylotarg was therefore pulled from the 
market by the FDA. Both neocarzinostatin 
and Mylotarg are highly toxic. 
1.4 Density functional theory  
 One of the main goals of 
computational chemistry is to predict the 
structure and properties of a molecule or 
material of interest. Acquiring information 
in this manner is particularly appealing 
when it is unfeasible, costly, or even 
impossible to obtain it directly through 
experiment. Given the elusive nature of 
didehydrobenzene molecules and their 
derivatives experimentally, it is hardly a 
surprise that these molecular species have 
been studied using theoretical methods. By 
the end of the 1990s, several high-level 
computational studies had been completed 
which accurately predicted the three 
didehydrobenzene isomers’ relative 
stabilities and singlet ground states.[24] 
 Electronic structure methods 
typically compute the energy of a particular 
configuration of atoms in space – a 
molecular geometry – based on the 
principles of quantum mechanics. This is 
accomplished by solving the famous 
Schrödinger equation ℋΨ = 𝐸Ψ to 
determine the wavefunction Ψ, from which 
various properties including the ground-state 
energy can be obtained. Even when nuclei 
are treated as stationary, for all but the very 
simplest atoms and molecules, this is a 
many-body problem requiring the 
simultaneous solution of so many 
differential equations that it is not feasible 
for modern computers. A large variety of 
methods exist in which different 
approximations to solution are employed to 
overcome this problem. Some, called semi-
empirical methods, use parameters with 
values obtained from experiment in order to 
simplify this process and save computational 
cost, but many others, called ab initio 
methods, only use quantum mechanical 
principles in addition to some fundamental 
physical constants. The most well-known ab 
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initio method, the Hartree-Fock method, 
constructs a many-electron wavefunction 
using single-electron wavefunctions in a 
manner that fulfills the Pauli exclusion 
principle, which an earlier method devised 
by Hartree failed to take into account. The 
Hartree-Fock method is based upon the 
variational theorem, so energies it obtains 
must be higher than the true ground-state 
energy of the molecule of interest. However, 
a fundamental limit to how close Hartree-
Fock calculations can get to the true energy 
exists due to the method’s neglect of a 
phenomenon called electron correlation. 
This shortcoming makes energies obtained 
by Hartree-Fock decent approximations, but 
also ones that ultimately fail to make valid 
predictions for many systems. 
 Many methods, generally called 
post-Hartree-Fock methods, have been 
devised to compensate for Hartree-Fock 
theory’s neglect of correlation. However, 
these are generally extremely 
computationally costly. A new method 
emerged in the 1960s called density 
functional theory (DFT), which greatly 
reduced computational cost and could in 
principle address both exchange and 
correlation effects. It arose from two 
important theorems proved by Hohenberg 
and Kohn: first, that the energy of a system 
was a function of a function (functional) of 
the electron density; and second, that the 
electron density which minimizes the energy 
is the true electron density.[25] DFT methods 
proceed by an iterative procedure whose 
goal is to solve self-consistent equations 
called Kohn-Sham equations;[26] for 
instance, an algorithm may begin by 
defining a trial electron density function 
from which the Kohn-Sham equations can 
be solved, then using the single-electron 
wavefunctions obtained to compute the 
electron density and check for convergence 
and proceed to a new iteration with an 
updated function if convergence is not 
achieved. The reduced computational cost of 
DFT arises from the significant reduction in 
the number of spatial variables in the 
equations by defining the electron density. 
 Computing the energy of a molecular 
geometry using electronic structure methods 
like Hartree-Fock and DFT can be 
complemented with methods of 
minimization so as to locate the geometry 
with the lowest energy (within the proximity 
of an initially provided geometry). Some of 
the more well known of these methods 
include steepest-descent and the Newton-
Raphson method. Geometries optimized in 
this manner are taken to be the geometry 
that the molecule would assume in reality 
with the corresponding computed energy. 
Modified versions of these methods may 
also be used to find local energy maxima 
rather than minima, allowing for transition 
state geometries and energies to be 
computed. Comparing how much higher a 
transition state’s energy is relative to the 
initial reactant molecule(s) allows for 
prediction of energetic barriers for the 
reaction. 
2. Materials and Methods 
2.1 Optimization of structural geometries 
and absolute energy determination 
The computational chemistry 
packages GAMESS[27] and Gaussian 09[28] 
were used to determine the structures of the 
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enediyne and two of its derivatives, aza-
enediyne and 1,2-dialkynylimidazole, as 
well as the products of their rearrangements 
(see section 1.3), using DFT. Because 
geometry optimization methods attempt to 
locate local minima in the neighborhood of 
an initially provided geometry, a roughly 
optimized geometry was first generated by 
building the molecules in a molecular 
editing program and subjecting them to 
energy minimization methods based upon 
molecular mechanics force fields. These 
geometries were then used as the initial 
inputs for the DFT optimizations. 
The optimization algorithms 
terminate based on whether the computed 
gradient of the energy is within some very 
small value (effectively zero), indicating that 
a stationary point on the potential energy 
surface has been reached. To further clarify 
that the correct type of stationary point has 
been reached, namely a local minimum, 
geometry optimizations were followed by 
frequency calculations, which compute the 
eigenvalues to the matrix of second partial 
derivatives of energy. The presence of only 
real frequencies validated that the algorithm 
successfully located a local minimum. 
For some optimizations – namely, 
the entire aza-enediyne series as well as all 
1,2-dialkynylimidazole series species under 
acidic conditions besides the diradical – Cs 
molecular symmetry was enforced within 
the calculation by Gaussian 09. All others, 
however, including those obtained by 
GAMESS, employed no symmetry 
constraints.  
In the cases of aza-enediyne and 1,2-
dialkynylimidazole, the effect of the choice 
of functional on the description of the 
molecules’ reactivity was examined by 
computing geometries using both the 
popular B3LYP and BPW91 functionals. In 
addition, for the aza-enediyne, the effect of 
basis set on the description was examined by 
performing computations using several 
Pople and correlation-consistent basis sets.  
2.2 Locating transition state geometries 
and computing energetic barriers 
 The procedure employed to obtain 
transition states was a bit more involved 
than for other species. For each transition 
state, the molecule’s geometry was 
optimized with the length of the bond 
formed or broken during the rearrangement 
fixed at several different values, first by 
molecular mechanics and then by DFT. The 
geometry that produced the highest energy 
was taken to be the one “closest” to an 
actual transition state (in some cases verified 
by frequency calculations) and was next 
subjected to an appropriate algorithm to 
further optimize the structure. The presence 
of one imaginary frequency following a 
frequency calculation was used to verify that 
a saddle point of the potential energy surface 
was reached, corresponding to a transition 
state. 
2.3 Description of diradical species 
 The theoretical description of 
diradical species, including transition states 
with high diradical character, has long been 
acknowledged as a formidable challenge due 
to the multiconfigurational nature of these 
species. Calculations of diradical 
intermediates and transition states with high  
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diradical character employed an unrestricted 
broken spin formalism. Although 
contamination of higher spin states can 
removed by a sum-correction method using 
the single-point triplet state energy at the 
broken-spin singlet geometry of the 
transition state,[29] this method was not 
employed in this work. The energies of 
diradical species in both singlet and triplet 
states will be presented, and transition state 
energies from singlet state calculations will 
be presented. 
3. Results  
 The aza-enediyne series was selected 
as the one on which the effect of basis set on 
the description of reactivity would be tested. 
All calculations employed the widely used  
B3LYP functional; energies were computed 
as the sum of the electronic energy and a 
zero-point correction calculated from the 
vibrational frequency analysis. With two 
exceptions, all optimized structures and their 
corresponding energies were successfully 
obtained. The results of this investigation 
are given in Table 1. 
Next, the enediyne and 1,2-
dialkynylimidazole series were similarly 
characterized using the B3LYP functional 
and the Pople 6-31G(d,p) basis set, in 
addition to these series under acidic 
conditions. All optimized structures and 
their corresponding energies were 
successfully determined except for transition 
states under acidic conditions. Data are 
given in Table 2 while schematic diagrams 
representing the data for the series under 
neutral conditions are given in Figures 10, 
11, and 12. 
 
	   1	   TS1-­‐2	   2S	   2T	   TS2-­‐3	   3	  
	  
3-­‐21G	  
	  
-­‐245.494	  
	  
	  
-­‐245.458	  
22.8	  
	  
-­‐245.496	  
-­‐1.3	  
	  
-­‐245.478	  
9.8	  
	  
–	  
	  
-­‐245.559	  
-­‐41.1	  
	  
6-­‐31G(d)	  
	  
-­‐246.857	  
	  
	  
-­‐246.822	  
21.8	  
	  
-­‐246.863	  
-­‐4.0	  
	  
-­‐246.849	  
4.6	  
	  
-­‐246.852	  
6.6	  
	  
-­‐246.916	  
-­‐37.2	  
	  
6-­‐31G(d,p)	  
	  
-­‐246.857	  
	  
	  
-­‐246.822	  
21.9	  
	  
-­‐246.868	  
-­‐6.9	  
	  
-­‐246.854	  
1.7	  
	  
-­‐246.858	  
-­‐0.5	  
	  
-­‐246.921	  
-­‐40.3	  
	  
cc-­‐pVDZ	  
	  
-­‐246.870	  
	  
	  
-­‐246.836	  
21.5	  
	  
-­‐246.881	  
-­‐6.9	  
	  
-­‐246.992	  
2.1	  
	  
-­‐246.871	  
-­‐0.8	  
	  
-­‐246.933	  
-­‐39.8	  
	  
cc-­‐pVTZ	  
	  
-­‐246.949	  
	  
	  
–	  
	  
-­‐246.950	  
-­‐0.8	  
	  
-­‐246.935	  
8.4	  
	  
-­‐246.942	  
3.8	  
	  
-­‐247.010	  
-­‐38.8	  
Table	  1.	  Calculated	  energies	  (hartree)	  of	  the	  aza-­‐enediyne	  series	  using	  the	  B3LYP	  functional	  and	  the	  indicated	  basis	  sets.	  	  1	  
represents	  the	  starting	  material,	  2	  the	  diradical,	  and	  3	  the	  product	  resulting	  from	  retro-­‐Bergman	  cyclization.	  All	  energies	  were	  
obtained	  by	  optimizations	  in	  which	  Cs	  symmetry	  was	  enforced.	  Failure	  to	  optimize	  the	  structure	  and	  compute	  the	  corresponding	  
energy	  is	  denoted	  by	  an	  emdash	  (–).	  For	  all	  species	  but	  1,	  a	  relative	  energy	  compared	  to	  1	  is	  also	  provided	  in	  kcal	  mol-­‐1.	  	  
Calculations	  were	  performed	  using	  Gaussian	  09.	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Table	  2.	  Calculated	  energies	  (hartree)	  of	  the	  enediyne,	  aza-­‐enediyne,	  and	  1,2-­‐dialkynylimidazole	  series	  under	  both	  neutral	  and	  acidic	  
conditions	  using	  the	  B3LYP	  functional	  and	  the	  Pople	  6-­‐31G(d,p)	  basis	  set.	  1,	  2,	  and	  3	  represent	  the	  corresponding	  species	  as	  in	  Table	  1;	  for	  
the	  1,2-­‐dialkynylimidazole	  series,	  4(T)	  represents	  the	  carbene	  resulting	  from	  the	  rearrangement	  of	  3	  in	  its	  triplet	  state.	  Failure	  to	  optimize	  
the	  structure	  and	  compute	  the	  corresponding	  energy	  is	  denoted	  by	  an	  emdash	  (–).	  Energies	  marked	  with	  an	  asterisk	  (*)	  were	  obtained	  by	  
optimizations	  in	  which	  Cs	  symmetry	  was	  enforced;	  all	  others	  employed	  no	  symmetry	  constraints.	  For	  all	  species	  but	  1,	  a	  relative	  energy	  
compared	  to	  1	  is	  also	  provided	  in	  kcal	  mol-­‐1.	  Except	  for	  the	  enediyne	  calculations,	  which	  were	  performed	  using	  GAMESS,	  all	  calculations	  
were	  performed	  using	  Gaussian	  09.	  
	  
	   Figure	  10.	  Reaction	  profile	  for	  the	  enediyne	  series.	  Energies,	  shown	  in	  hartree,	  were	  computed	  by	  B3LYP/6-­‐31G(d,p)	  using	  GAMESS.	  
Energy	  shown	  for	  the	  diradical	  is	  for	  its	  singlet	  state;	  singlet-­‐triplet	  splitting	  value	  is	  given	  in	  parentheses	  in	  kcal	  mol-­‐1.	  
	   	   1	   TS1-­‐2	   2S	   2T	   	   	   	   	  
enediyne	   	   -­‐230.669	  
	  
-­‐230.620	  
30.7	  
	  
-­‐230.661	  
5.4	  
-­‐230.656	  
8.1	  
	   	   	   	  
	   	   1	   TS1-­‐2	   2S	   2T	   TS2-­‐3	   3	   	   	  
	  
aza-­‐enediyne	  
neutral	   -­‐246.857*	  
	  
-­‐246.822*	  
21.9	  
-­‐246.868*	  
-­‐6.9	  
-­‐246.854*	  
1.7	  
-­‐246.858*	  
-­‐0.5	  
-­‐246.921*	  
-­‐40.3	  
	   	  
acidic	   -­‐247.189*	  
	  
–	   -­‐247.195*	  
-­‐3.9	  
-­‐247.190*	  
-­‐0.7	  
	  
–	   -­‐247.236*	  
-­‐29.7	  
	  
	   	  
	   	   1	   TS1-­‐2	   2S	   2T	   TS2-­‐3	   3	   TS3-­‐4	   4(T)	  
	  
1,2-­‐
dialkynylimidazole	  
neutral	   -­‐378.403	  
	  
-­‐378.361	  
25.9	  
-­‐378.387	  
9.7	  
-­‐378.378	  
15.4	  
-­‐378.384	  
11.7	  
-­‐378.422	  
-­‐12.4	  
-­‐378.396	  
3.9	  
-­‐378.422	  
-­‐12.3	  
acidic	   -­‐378.765*	  
	  
–	   -­‐378.753	  
7.7	  
-­‐378.747	  
11.7	  
–	   -­‐378.782*	  
-­‐10.6	  
–	   -­‐378.770*	  
-­‐2.9	  
	  
	  	  	  	  (2.7)	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  (8.6)	  
	  
	  
(5.7)	  
Figure	  11.	  Reaction	  profile	  for	  the	  aza-­‐enediyne	  series.	  Energies,	  shown	  in	  hartree,	  were	  computed	  by	  B3LYP/6-­‐31G(d,p)	  using	  Gaussian	  
09.	  Energy	  shown	  for	  the	  diradical	  is	  for	  its	  singlet	  state;	  singlet-­‐triplet	  splitting	  value	  is	  given	  in	  parentheses	  in	  kcal	  mol-­‐1.	  
Figure	  12.	  Reaction	  profile	  for	  the	  1,2-­‐dialkynylimidazole	  series.	  Energies,	  shown	  in	  hartree,	  were	  computed	  by	  B3LYP/6-­‐31G(d,p)	  using	  
Gaussian	  09.	  Energy	  shown	  for	  the	  diradical	  is	  for	  its	  singlet	  state	  while	  the	  energy	  for	  the	  carbene	  is	  for	  its	  triplet	  state;	  singlet-­‐triplet	  
splitting	  value	  of	  the	  diradical	  is	  given	  in	  parentheses	  in	  kcal	  mol-­‐1.	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 A number of the aforementioned 
calculations were also performed using both 
GAMESS and Gaussian. Discrepancies in 
the absolute energy values obtained by the 
two packages were noted early, so both 
absolute and relative energies were 
compared to investigate whether the 
package used to perform the computations 
affected the description of the reaction. 
These data are given in Table 3. 
Finally, the aza-enediyne and 1,2-
dialkynylimidazole systems were 
characterized using the BPW91 functional 
and the cc-pVDZ basis set. Data are 
provided in Table 4. 
  
 
 
 
 
 
 
 
 
	   	   1	   TS1-­‐2	   2S	   2T	   TS2-­‐3	   3	   	   	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
aza-­‐enediyne	  
	  
	  
3-­‐21G	  
-­‐245.346	  
	  
92.6	  
-­‐245.310	  
22.8	  
92.6	  
-­‐245.348	  
-­‐1.2	  
92.7	  
-­‐245.331	  
9.8	  
92.6	  
–	   -­‐245.412	  
-­‐41.1	  
92.6	  
	   	  
	  
	  
6-­‐31G(d)	  
-­‐246.704	  
	  
95.9	  
-­‐246.669	  
21.8	  
95.9	  
–	  
	  
-­‐246.702	  
1.3	  
92.6	  
-­‐246.705	  
-­‐0.6	  
92.7	  
-­‐246.768	  
-­‐40.8	  
92.6	  
	   	  
	  
	  
6-­‐31G(d,p)	  
-­‐246.709	  
	  
92.6	  
	  
-­‐246.675	  
21.8	  
92.6	  
-­‐246.720	  
-­‐6.9	  
92.6	  
-­‐246.707	  
1.7	  
92.6	  
-­‐246.710	  
-­‐0.4	  
92.6	  
-­‐246.774	  
-­‐40.4	  
92.6	  
	   	  
	  
	  
cc-­‐pVDZ	  
-­‐246.722	  
	  
92.6	  
	  
-­‐246.688	  
21.5	  
92.5	  
–	  
	  
-­‐246.719	  
2.1	  
92.6	  
-­‐246.724	  
-­‐0.7	  
92.7	  
-­‐246.786	  
-­‐39.1	  
92.6	  
	   	  
	  
	  
cc-­‐pVTZ	  
-­‐246.801	  
	  
92.6	  
	  
-­‐246.762	  
24.6	  
–	  
	  
-­‐246.787	  
8.5	  
92.6	  
–	  
	  
-­‐246.863	  
-­‐38.8	  
92.6	  
	   	  
	   	   1	   TS1-­‐2	   2S	   2T	   TS2-­‐3	   3	   TS3-­‐4	   4(T)	  
	  
1,2-­‐
dialkynylimidazole	  
	  
	  
6-­‐31G(d,p)	  
-378.181 
	  
139.3	  
-378.140 
25.8	  
139.3	  
–	  
 
-378.156 
15.3	  
139.2	  
–	  
	  
-378.201 
-­‐12.5	  
139.3	  
-378.174 
4.0	  
139.3	  
-378.200 
-­‐12.4	  
139.2	  
	  
Table	  3.	  Calculated	  energies	  (hartree)	  of	  the	  aza-­‐enediyne	  and	  1,2-­‐dialkynylimidazole	  series	  using	  the	  B3LYP	  functional	  and	  the	  indicated	  
basis	  sets.	  All	  calculations	  were	  performed	  by	  GAMESS	  and	  employed	  no	  symmetry	  restrictions.	  Failure	  to	  optimize	  the	  structure	  and	  
compute	  the	  corresponding	  energy	  is	  indicated	  by	  an	  emdash	  (–).	  	  For	  all	  species	  but	  1,	  a	  relative	  energy	  compared	  to	  1	  is	  also	  provided	  in	  
kcal	  mol-­‐1.	  For	  all	  species,	  a	  relative	  energy	  compared	  to	  that	  provided	  by	  the	  equivalent	  calculation	  using	  Gaussian	  09	  Is	  also	  provided	  in	  
kcal	  mol-­‐1	  (italicized).	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4. Discussion 
4.1 DFT predicts cyclization barriers in 
good agreement with available 
experimental data 
Experiment gives an energetic 
barrier to cyclization of 28.7 kcal mol-1 for 
the enediyne.[30] The value obtained by DFT 
using the B3LYP functional and 6-31G(d,p) 
basis set differed little: at 30.7 kcal mol-1, it 
is only 2.0 kcal mol-1 higher than the 
experimentally obtained value.	   
 Theoretical values for the barrier to 
the aza-enediyne’s cyclization ranged from 
21.5 to 24.6 kcal mol-1 when computed 
using the B3LYP functional. Nearly without 
exception, these values are in excellent 
agreement with the experimentally derived 
value of 22.5 ± 1.5 kcal mol-1 (for a close 
analog of the aza-enediyne).[31] Computing 
this barrier using the BPW91 functional 
provided poorer agreement, at only 15.3 kcal 
mol-1. Because transition states for the 
protonated aza-enediyne had not been found 
at the time of this writing, an energetic 
barrier for this molecule under sufficiently 
acidic conditions could not be predicted. 
Experimental data for the barrier to 1,2-
dialkynylimidazole cyclization was not 
found, though some exists for a similar 
molecule with a large substituent at one 
acetylenic position, whose energetic barrier 
to cyclization is 30.0 kcal mol-1.[32] 
Intuitively, the 1,2-dialkynylimidazole 
lacking this substituent would have a lower 
energetic barrier to cyclization; indeed, the 
barrier predicted by DFT is 25.9 kcal mol-1. 
4.2 The DFT description of the aza-
enediyne does not depend strongly on the 
choice of basis set 
 In general, the choice of basis set did 
not have a major effect on the description of 
the aza-enediyne’s reactivity when all 
calculations were performed using the same 
functional. For instance, all basis sets 
predicted a barrier to cyclization within 1 
	   	   1	   TS1-­‐2	   2S	   2T	   TS2-­‐3	   3	   	   	  
	  
aza-­‐enediyne	  
neutral	   -­‐246.848*	  
	  
-­‐246.823*	  
15.3	  
-­‐246.869*	  
-­‐13.6	  
-­‐246.846*	  
0.8	  
-­‐246.860*	  
-­‐7.7	  
-­‐246.908*	  
-­‐37.9	  
	   	  
acidic	   -­‐247.175*	  
	  
–	   -­‐247.184*	  
-­‐5.7	  
-­‐247.177*	  
-­‐1.4	  
	  
–	   -­‐247.221*	  
-­‐29.2	  
	  
	   	  
	   	   1	   TS1-­‐2	   2S	   2T	   TS2-­‐3	   3	   TS3-­‐4	   4	  
	  
1,2-­‐
dialkynylimidazole	  
neutral	   -­‐378.384	  
	  
–	   -­‐378.382	  
1.2	  
-­‐378.368	  
10.0	  
–	   -­‐378.412	  
-­‐17.6	  
-­‐–	   -­‐378.408	  
-­‐15.3	  
acidic	   -­‐378.750*	  
	  
–	   -­‐378.744	  
3.7	  
-­‐378.735	  
9.1	  
–	   -­‐378.771*	  
-­‐13.1	  
–	   -­‐378.759*	  
-­‐5.9	  
	  Table	  4.	  Calculated	  energies	  (hartree)	  of	  the	  aza-­‐enediyne	  and	  1,2-­‐dialkynylimidazole	  series	  under	  both	  neutral	  and	  acidic	  conditions	  using	  
the	  BPW91	  functional	  and	  the	  cc-­‐pVDZ	  basis	  set.	  All	  calculations	  were	  performed	  by	  Gaussian	  09.	  Energies	  marked	  with	  an	  asterisk	  (*)	  were	  
obtained	  by	  optimizations	  in	  which	  Cs	  symmetry	  was	  enforced;	  all	  others	  employed	  no	  symmetry	  constraints.	  Failure	  to	  optimize	  the	  
structure	  and	  compute	  the	  corresponding	  energy	  is	  indicated	  by	  an	  emdash	  (–).	  	  For	  all	  species	  but	  1,	  a	  relative	  energy	  compared	  to	  1	  is	  
also	  provided	  in	  kcal	  mol-­‐1.	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kcal mol-1 of one another, and all basis set 
choices yielded the same predicted reactivity 
based on the criteria of Kraka and Cremer. 
However, performing the calculations using 
the BPW91 functional provided very 
different energetic barriers; though the 
trends in stability remained the same as 
those predicted by B3LYP, relative energies 
differed greatly. Furthermore, as noted 
previously, the energetic barriers predicted 
by BPW91 computations were lower than 
what the experimental literature suggests. 
4.3 Predicted fates of enediyne analogs in 
vivo 
 The predicted energetic barrier to 
enediyne cyclization, at 30.7 kcal mol-1, is 
significantly higher than 24 kcal mol-1. 
Assuming the criteria of Kraka and Cremer 
hold, this species is therefore predicted not 
to cyclize under physiological conditions at 
neutral pH. Because the molecule lacks 
atoms or functional groups that would be 
readily protonated, under acidic conditions 
its reactivity is predicted to be similar. 
 Based on the aforementioned 
energetic barriers obtained by DFT, the aza-
enediyne would be predicted to cyclize to its 
diradical form under neutral conditions. 
However, all calculations predict barriers far 
below 14 kcal mol-1 for the rearrangement of 
the diradical species to its retro-Bergman 
cyclization product, an enynenitrile. 
Furthermore, due to its fairly high singlet-
triplet splitting value – consistently 
predicted to be over 8 kcal mol-1 – the 
diradical species is predicted to be 
unreactive in hydrogen abstraction reactions, 
in accordance with the proposed idea that 
low singlet-triplet splitting corresponds to 
high hydrogen abstraction ability.[33] 
Therefore, under neutral conditions, the aza-
enediyne is predicted to cyclize to a fairly 
unreactive diradical form then be rapidly 
converted to its stable enynenitrile form. 
The absence of computed transition state 
energies for the protonated aza-enediyne 
precludes a full prediction of the molecule’s 
behavior under acidic conditions; however, 
it may be noted that the relative stabilities of 
the protonated species follow the same trend 
as for the unprotonated ones. Furthermore, 
the singlet-triplet gap reduces significantly, 
to around 4 kcal mol-1; the protonated 
diradical, then, is predicted to have greater 
hydrogen abstraction ability than its 
unprotonated counterpart. 
 DFT predicted the cyclization barrier 
for 1,2-dialkynylimidazole under neutral 
conditions to be 25.9 kcal mol-1, just above 
24 kcal mol-1. By the criteria proposed by 
Kraka and Cremer, this barrier is slightly too 
high for significant cyclization of 1,2-
dialkynylimidazole to occur under 
physiological conditions. The diradical 
species, if generated, would likely be 
fleeting, as the barrier for the retro-Bergman 
rearrangement is significantly lower than 14 
kcal mol-1; moreover, as evidenced by its 
high singlet-triplet gap, it would be 
unreactive. The relative stability of the nine-
membered cumulene ring formed by the 
retro-Bergman rearrangement at first seems 
odd due to its significant strain; however, 
this seemingly surprising observation may 
be rationalized by noting that one of the 
molecule’s resonance contributors is 
aromatic, conferring it great stability. Again, 
the failure to compute transition state 
geometries and energies for the protonated 
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form of this molecule precludes a full 
prediction of its behavior under acidic 
conditions, but as with the aza-enediyne, the 
same general trend of stability follows as 
with the unprotonated molecule, and 
protonation significantly reduces the singlet-
triplet gap of the diradical species. 
4.4 Absolute energies, but not relative 
energies, depend strongly on the software 
package used to compute them 
 The unexpected discrepancy between 
absolute energies computed by GAMESS 
and by Gaussian 09 should be noted. Table 3 
highlights this observation; although the 
relative energies between species computed 
by GAMESS are nearly always very close 
(within tenths of a kcal mol-1) to those 
computed by Gaussian (Table 1), they differ 
in absolute energy by a significant margin. 
Curiously, the discrepancy is consistent; for 
all aza-enediyne calculations, it rarely 
deviated more than 0.1 kcal mol-1 from 92.6 
kcal mol-1, and the same held true for 1,2-
dialkynylimidazole calculations, though 
with a consistent difference in 139.2 kcal 
mol-1. The reasons for these differences are 
unclear (to this naïve author), but because 
they are of such a significant magnitude, 
they nonetheless emphasize the importance 
of noting the source of theoretically obtained 
energetic data, whether comparing to prior 
studies in the literature or one’s own 
previous studies. 
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